Background: Human papillomavirus (HPV) vaccines were introduced to the market in 2006
and 2007. The present pilot study was designed to examine the incidence of genital warts in …

José A Caminero and colleagues1 recently reviewed drug treatments for multidrug-resistant
(MDR) and extensively drug-resistant (XDR) tuberculosis, and a 2010 WHO report2 on XDR …

Abstract Introduction: World Health Organization estimates that 291 million women
worldwide will have a human papillomavirus infection. Treatment for genital warts brings …

abstract Background: Schools are the primary setting for the delivery of adolescent HPV
vaccination in Australia. Although this strategy has achieved generally high vaccination …

La prévalence des condylomes ano-génitaux externes (CAE), liés aux papillomavirus
(HPV), a augmenté durant ces dernières décennies [1-5]. L'incidence annuelle des CAE est …

Background: External genital warts (EGW), also known as condyloma acuminata (CA) is
caused by Human Papilloma Virus (HPV) and is the most frequent sexually transmitted viral …

A comment on this article appears in" For debate: that Australia should consider changing to
the bivalent vaccine." Sex Health. 2010 Sep; 7 (3): 238-41. A comment on this article …

Klinisch-epidemiologische Forschung anhand von Daten der gesetzlichen Krankenkassen –
Grenzen und Möglichkeiten Dissertation Page 1 Klinisch-epidemiologische Forschung …

The article presents a case study of a 23 year old pregnant woman who presented to
physicians at an antenatal clinic with symptoms of pink vaginal discharge and lower …

Human papillomaviruses (HPVs) are a group of over 100 viruses, of which approximately 40
types are transmitted via genital contact. HPV is the most common sexually transmitted …